Filing Details
- Accession Number:
- 0001645627-18-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-29 12:46:38
- Reporting Period:
- 2018-08-27
- Accepted Time:
- 2018-08-29 12:46:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 63,400 shares | Avg. Price: $0.04 | Total Value: $2,378.05 |
| Number of Shares After Transactions: | 25,786,098 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-27 | 2,000 | $0.03 | 25,724,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 2,500 | $0.03 | 25,727,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 2,000 | $0.04 | 25,729,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 3,000 | $0.04 | 25,732,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 2,000 | $0.03 | 25,734,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 2,000 | $0.04 | 25,736,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 1,500 | $0.03 | 25,737,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 2,000 | $0.04 | 25,739,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 2,000 | $0.03 | 25,741,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 2,000 | $0.04 | 25,743,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 3,000 | $0.03 | 25,746,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 2,000 | $0.03 | 25,748,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-27 | 3,000 | $0.03 | 25,751,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,753,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,755,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 1,000 | $0.04 | 25,756,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,758,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,760,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,762,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,764,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 3,000 | $0.04 | 25,767,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 1,000 | $0.04 | 25,768,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,770,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,772,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 3,000 | $0.04 | 25,775,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,777,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 3,000 | $0.04 | 25,780,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 3,000 | $0.04 | 25,783,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 2,000 | $0.04 | 25,785,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-28 | 400 | $0.04 | 25,786,098 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
